Role Of Beta-Blockers In Thyroid Storm: Controlling Tachycardia And Other Adrenergic Symptoms
Published on: May 26, 2025
Role of Beta-Blockers in Thyroid Storm Controlling tachycardia and other adrenergic symptoms
Article author photo

Vinuth G U

Masters, Pharmacology, PES University

Article reviewer photo

Melissa Merouani

doctor of pharmacy

Introduction

Thyroid storm is an acute and life-threatening worsening of hyperthyroidism that features extreme symptoms like tachycardia, hyperthermia, and changes in mental status.1

Adrenergic signs such as tachycardia and hypertension are lead features due to increased sympathetic nervous activity owing to excess thyroid hormones.2

Beta-blockers play a crucial role in controlling such symptoms by blocking beta-adrenergic receptors, thus inhibiting the actions of excess catecholamines.

Pathophysiology

Excessive release of thyroid hormones results in high sensitivity of beta-adrenergic receptors.4

This leads to elevated heart rate, contractility, and peripheral vasodilation, which add to the clinical presentation of thyroid storm.5

Role of beta-blockers in management

Beta-blockers reduce symptoms by inhibiting beta-adrenergic receptors, lowering heart rate and myocardial oxygen demand, and suppressing arrhythmias.3

They also reduce peripheral tremors and anxiety due to adrenergic hyperactivity.6 

The effect on cardiovascular health-related symptoms

Cardiovascular effects present the most dangerous complication of thyroid storm , especially tachycardia, and arrhythmias. Beta-blockers, especially propranolol, reduce the heart rate and enhance hemodynamic stability.1

Along with their crucial function in the control and regulation of cardiac rate, beta-blockers have a powerful preventative action in the development of atrial fibrillation, a common finding in thyrotoxicosis patients. Various studies indicate that beta-blocker treatment not only permits effective control of rate but also prevents, to a considerable extent, the development of heart failure in hyperthyroid patients.2 

Effects on metabolism

Propranolol belongs to non-selective beta blockers, and has another benefit along with its chief action. It actively suppresses the conversion of the thyroid hormone T4 into the more biologically active hormone T3. Via inhibiting the enzyme 5'-deiodinase, which converts T4 to T3. By this process, the net biological activity of thyroid hormones is further reduced. This suppression of thyroid hormone action is useful because it supports the effective treatment and hyperthyroidism symptoms control.4,6

Effect on the peripheral nervous system with symptoms

Thyroid storm is characterised by a wide range of pronounced adrenergic symptoms that are extremely uncomfortable, such as tremors, heightened anxiety, excessive sweating, or diaphoresis. The use of beta-blockers has proved to be useful in managing such uncomfortable symptoms by lowering the sympathetic stimulation levels in the body.5

Selection of beta blockers

Non-selective beta-blockers such as propranolol are usually recommended because they have the extra advantage of blocking peripheral conversion of T4 to T3.4

Selective beta-1 blockers like metoprolol can be prescribed for patients with contraindications to non-selective drugs, such as asthma or chronic obstructive pulmonary disease.2 

Clinical efficacy and safety

Beta-blockers achieve immediate control over tachycardia and other adrenergic manifestations of thyroid storm.3

Possible side effects are bradycardia, hypotension, and, in a few instances, bronchospasm.7

Rigorous observation and dose titration are necessary to balance therapeutic advantages against possible side effects.5

Adjunctive therapies

Beta-blockers are combined with antithyroid drugs, such as propylthiouracil or methimazole to decrease thyroid hormone production.6

Supportive therapy, such as fluid resuscitation, cooling manoeuvres, and corticosteroids, is critical in total management.1

Multidisciplinary evaluation guarantees immediate identification and treatment of thyroid storm, enhancing the outcomes of the patient.5 

Influence of polymorphism

General polymorphisms of the vitamin D receptor gene were found to impact the risk of breast, colon, prostate, and differentiated thyroid cancer (DTC), but polymorphisms in the genes of vitamin D metabolising enzymes were not investigated in DTC.

The research examined the enzyme genes and status of vitamin D (25-hydroxyvitamin D(3) calcidiol, and 1,25-dihydroxyvitamin D(3) calcitriol) in DTC patients and healthy controls (HC) which lead to the discovery of no variation in the genotypes; however, the CYP24A1(cytochrome P450 enzyme that catalyses the conversion of calcidiol and calcitriol into inactive metabolites) haplotype analysis revealed that it was less common in the papillary thyroid carcinoma (PTC), while the haplotypes were more common in the follicular thyroid carcinoma (FTC) than in HC.

In addition, when patients and controls were divided into four groups (severely deficient, deficient, insufficient, and sufficient), then the two subtypes of DTC patients had significantly reduced circulating calcitriol levels, particularly among the deficient calcidiol status group compared with the controls. Though the polymorphisms did not differ when stratified according to the four categories of calcidiol, activation by calcitriol differed significantly in relation to the genotypes of CYP24A1 polymorphisms investigated.

The study concluded that increased risk of DTC is imparted by haplotypes in the CYP24A1 gene, low circulating levels of calcidiol (deficiency), and decreased conversion to calcitriol. These findings validate and extend earlier observations and also provide evidence for a role of the vitamin D system in the pathogenesis of DTC. How calcidiol deficiency levels combined with some CYP24A1 haplotypes influence vitamin D activation is a matter of future research.1 

FAQs

Why are beta-blockers used in thyroid storm? 

They control tachycardia, prevent arrhythmias, and reduce adrenergic symptoms.

Which beta-blocker is preferred? 

Propranolol, due to its additional effect of reducing T4 to T3 conversion.

Can beta-blockers be used alone

No, they are adjunctive therapy alongside antithyroid drugs and supportive care.

Are there any contraindications for beta-blockers in thyroid storm? 

Yes, conditions like asthma, severe bradycardia, and decompensated heart failure require caution.

How quickly do beta-blockers work in thyroid storm

Effects on heart rate and symptoms are often seen within a few hours of administration.

What are the side effects of beta-blockers?

Potential side effects include bradycardia, hypotension, dizziness, fatigue, and bronchospasm in susceptible individuals.

Can beta-blockers prevent thyroid storm in hyperthyroid patients?

Yes, beta-blockers are often prescribed to patients with severe thyrotoxicosis to prevent progression to thyroid storm, especially in those with high heart rates.

Is metoprolol a good alternative to propranolol?

Yes, metoprolol can be used in patients who cannot tolerate propranolol, particularly those with respiratory conditions. However, it lacks the T4 to T3 conversion inhibition effect.

What happens if a thyroid storm patient cannot tolerate beta-blockers?

If beta-blockers are contraindicated, calcium channel blockers like diltiazem may be used to control heart rate.

Summary

Thyroid storm is a dangerous, acute manifestation of thyrotoxicosis with hyperadrenergic features of tachycardia, hyperthermia, and mental status alteration. It usually happens in hyperthyroid patients with precipitating stressors such as infection, surgery, or trauma. The excess of thyroid hormones causes beta-adrenergic receptor hypersensitivity, which enhances cardiovascular and metabolic derangements.

Beta-blockers are a crucial component of the effective management of thyroid storm, primarily through adrenergic inhibition that leads to severe complications. The most important role they play is the management of cardiovascular symptoms, primarily the prevention of such conditions as tachycardia and other arrhythmias that are present in the crisis. Among the choices available, the non-selective beta-blocker propranolol is typically the drug of choice because not only is it effective in controlling heart rate but also can control peripheral conversion of thyroxine (T4) to triiodothyronine (T3). Inhibition of the conversion subsequently leads to a reduction of the total activity of thyroid hormones, which is vital in managing symptoms of thyroid storm. When the use of propranolol is deemed to be contraindicated, such as asthma or other respiratory disease, other drugs like cardio-selective beta-blockers including metoprolol or atenolol can be appropriately used to provide the targeted therapeutic effect without the potential for side effects.

Besides cardiovascular control, beta-blockers also ease peripheral signs of thyroid storm, including tremor, anxiety, and diaphoresis. Clinical experience mirrors efficacy, with dramatic relief from symptoms within hours of receiving the drug. Side effects, such as bradycardia, hypotension, bronchospasm, and exacerbation of heart failure, necessitate careful patient selection and monitoring.

Since beta-blockers do not treat the underlying hyperthyroidism, they are combined with antithyroid medications such as methimazole and propylthiouracil (PTU), corticosteroids for T4-to-T3 inhibition, and supportive care such as fluid resuscitation and fever control.

Overall, beta-blockers are a major part of thyroid storm treatment, because they significantly enhance the prognosis of the condition through the suppression of adrenergic hyperactivity, especially when it comes to tachycardia. Through their integration into an effectively organised treatment program, the medications help enhance the survival rate of patients as well as the healing process.

References

  • Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, et al. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid. 2012 Jul;22(7):709–16.
  • Guettier JM, Gorden P. Hypoglycemia. Endocrinol Metab Clin North Am. 2006 Dec;35(4):753–66, viii–ix.
  • João Oliveira M, Rodrigues F, Pereiras C, Borges F, Carrilho F, Limbert E, et al. Treatment of differentiated thyroid carcinoma: a survey. Endocrinol Nutr. 2008 Aug;55(7):283–8.
  • Byfield JE. Adriamycin cardiac toxicity: a different hypothesis. Cancer Treat Rep. 1977;61(3):497–8.
  • Lee CJ, Chung TN, Bae J, Kim EC, Choi SW, Kim OJ. 50% duty cycle may be inappropriate to achieve a sufficient chest compression depth when cardiopulmonary resuscitation is performed by female or light rescuers. Clin Exp Emerg Med. 2015 Mar;2(1):9–15.
  • Sakurai A, Miyamoto T, Hughes IA, DeGroot LJ. Characterization of a novel mutant human thyroid hormone receptor beta in a family with hereditary thyroid hormone resistance. Clin Endocrinol (Oxf). 1993 Jan;38(1):29–38.

Share

Vinuth G U

Masters, Pharmacology, PES University

arrow-right